Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Apr 10, 2016; 8(7): 330-337
Published online Apr 10, 2016. doi: 10.4253/wjge.v8.i7.330
Table 2 Risk factor associated with neoplasia recurrence
RecurrenceNo recurrenceUnivariateMultivariate
n = 36n = 379P valueP value
Age, yr (mean ± SD)66.7 ± 9.064.0 ± 9.90.11
Male/female25/11266/1130.93
Tumor margin, n (%)0.020.03
Well-defined24 (66.7)313 (82.6)
Ill-defined12 (33.3)66 (17.4)
Tumor size, n (%)0.62
≤ 20 mm9 (25.0)107 (28.2)
21-30 mm6 (16.7)71 (18.7)
31-40 mm14 (38.9)108 (28.5)
> 40 mm7 (19.4)93 (24.5)
Tumor location, n (%)0.05
Upper3 (8.3)12 (3.2)
Mid14 (38.9)115 (30.3)
Lower19 (52.8)252 (66.5)
Histology, n (%)0.7
Well differentiated17 (47.2)178 (47.0)
Moderate differentiated13 (36.1)167 (44.1)
Poorly differentiated6 (16.7)24 (6.3)
Signet ring cell0 (0.0)10 (2.6)
Procedure time, min (mean ± SD)63.5 ± 56.948.8 ± 34.30.020.06
Safety margin, mm (mean ± SD)3.1 ± 2.14.2 ± 2.90.030.05